Eduardo Miranda Dantas

Eduardo Miranda Dantas

Auto-generated profile, based on publicly available information

Eduardo Miranda Dantas

Collegiate of Biological Sciences, Federal University of Vale do São Francisco, Petrolina, Brazil

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2013 in Revista de Saúde Pública
Verified
Journal Article
Open access
PDF file
JMJose Geraldo Mill
Jose Geraldo Mill
KPKarina Pinto
Karina Pinto
RGRosane H. Griep
Rosane H. Griep
AGAlessandra Goulart
Alessandra Goulart
MFMurilo Foppa
Murilo Foppa
IBIsabela M Bensenor
Isabela M Bensenor
Este artigo descreve os exames clínicos realizados no Estudo Longitudinal de Saúde do Adulto (ELSA-Brasil). Alguns deles (antropometria, pressão arterial e índice tornozelo-braquial) já têm uso clínico consolidado. Outros, como a velocidade de onda de pulso, variabilidade da frequência cardíaca e medida da espessura médio-intimal de carótidas, carecem de valor de referência na população brasileira não doente e podem constituir preditores importantes de desfechos cardiovasculares. A medida da pressão arterial após manobra postural foi incluída no ELSA-Brasil porque foi pouco testada em estudos epidemiológicos. O ELSA-Brasil inovou na realização do índice tornozelo-braquial, ao usar um aparelho automático em substituição à coluna de mercúrio na medida da pressão arterial, e também na medida do diâmetro ântero-posterior do lobo direito do fígado pela ultrassonografia, proposta para avaliação quantitativa da doença hepática gordurosa não-alcoólica. Os participantes são indivíduos mais jovens (a partir dos 35 anos) do que em outras coortes focadas no estudo da aterosclerose subclínica. A inclusão de indivíduos mais jovens e a diversidade dos exames realizados tornam o ELSA-Brasil um estudo relevante no contexto da epidemiologia brasileira e internacional.

1 December 2014 in American Journal of Psychiatry
Verified
Journal Article
Closed access
AKAndrew Haddon Kemp
Andrew Haddon Kemp
ABAndre R. Brunoni
Andre R. Brunoni
ISItamar Santos
Itamar Santos
MNMaria A. Nunes
Maria A. Nunes
EDEduardo M. Dantas
Eduardo M. Dantas
PLPaulo A. Lotufo
Paulo A. Lotufo

1 January 2013 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
ABAndre R. Brunoni
Andre R. Brunoni
MVMarie-Anne Vanderhasselt
Marie-Anne Vanderhasselt
PBPaulo S. Boggio
Paulo S. Boggio
Felipe FregniFelipe Fregni
Felipe Fregni
EDEduardo Miranda Dantas
Eduardo Miranda Dantas
IBIsabela M. Benseñor
Isabela M. Benseñor

1 October 2013 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
ABAndre R. Brunoni
Andre R. Brunoni
AKAndrew Haddon Kemp
Andrew Haddon Kemp
EDEduardo M. Dantas
Eduardo M. Dantas
AGAlessandra C. Goulart
Alessandra C. Goulart
MNMaria Angélica Nunes
Maria Angélica Nunes
IBIsabela M. Benseñor
Isabela M. Benseñor
Decreased heart rate variability (HRV) is a cardiovascular predictor of mortality. Recent debate has focused on whether reductions in HRV in major depressive disorder (MDD) are a consequence of the disorder or a consequence of pharmacotherapy. Here we report on the impact of transcranial direct current stimulation (tDCS), a non-pharmacological intervention, vs. sertraline to further investigate this issue. The employed design was a double-blind, randomized, factorial, placebo-controlled trial. One hundred and eighteen moderate-to-severe, medication-free, low-cardiovascular risk depressed patients were recruited for this study and allocated to either active/sham tDCS (10 consecutive sessions plus two extra sessions every other week) or placebo/sertraline (50 mg/d) for 6 wk. Patients were age and gender-matched to healthy controls from a concurrent cohort study [the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)]. The impact of disorder, treatment and clinical response on HRV (root mean square of successive differences and high frequency) was examined. Our findings confirmed that patients displayed decreased HRV relative to controls. Furthermore, HRV scores did not change following treatment with either a non-pharmacological (tDCS) or pharmacological (sertraline) intervention, nor did HRV increase with clinical response to treatment. Based on these findings, we discuss whether reduced HRV is a trait-marker for MDD, which may predispose patients to a host of conditions and disease even after response to treatment. Our findings have important implications for our understanding of depression pathophysiology and the relationship between MDD, cardiovascular disorders and mortality.

20 March 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MGMaria Bernadete Renoldi Oliveira Gavi
Maria Bernadete Renoldi Oliveira Gavi
DVDalton Valentin Vassalo
Dalton Valentin Vassalo
FAFabian Tadeu Amaral
Fabian Tadeu Amaral
DMDanielle Constância Felício Macedo
Danielle Constância Felício Macedo
PGPablo Lúcio Gava
Pablo Lúcio Gava
VVValeria Valim
Valeria Valim
Autonomic dysfunction is an important mechanism that could explain many symptoms observed in fibromyalgia (FM). Exercise is an effective treatment, with benefits potentially mediated through changes in autonomic modulation. Strengthening is one of the less studied exercises in FM, and the acute and chronic effects of strengthening on the autonomic system remain unknown. The objective of this study was to assess the chronic effects of strengthening exercises (STRE) on autonomic modulation, pain perception and the quality of life (QOL) of FM patients. Eighty sedentary women with FM (ACR 1990) were randomly selected to participate in STRE or flexibility (FLEX) exercises in a blinded controlled trial. The intensity of STRE was set at 45% of the estimated load of 1 Repetition Maximum (RM) in 12 different exercises. Outcomes were Visual Analog Scale (VAS) for pain, Heart Rate Variability (HRV) analysis, treadmill test, the sit and reach test (Wells and Dillon’s Bench), maximal repetitions test and handgrip dynamometry; and quality of life by the Fibromyalgia Impact Questionnaire (FIQ), the Beck and Idate Trait-State Inventory (IDATE), a short-form health survey (SF-36). The STRE group was more effective to strength gain for all muscles and pain control after 4 and 16 weeks (p<0.05). The FLEX group showed higher improvements in anxiety (p<0.05). Both groups showed improvements in the QOL, and there was no significant difference observed between the groups. There was no change in the HRV of the STRE and FLEX groups. Strengthening exercises show greater and more rapid improvements in pain and strength than flexibility exercises. Despite the benefits in fitness, pain, depression, anxiety and quality of life, no effect was observed on the autonomic modulation in both groups. This observation suggests that changes in autonomic modulation are not a target tobe clinically achieved in fibromyalgia. ClinicalTrials.gov NCT02004405

2 January 2018 in Psychophysiology
Verified
Journal Article
Closed access
PDF file
EDEduardo Miranda Dantas
Eduardo Miranda Dantas
AKAndrew Haddon Kemp
Andrew Haddon Kemp
RARodrigo Varejão Andreão
Rodrigo Varejão Andreão
VSValdo José Dias da Silva
Valdo José Dias da Silva
ABAndre R. Brunoni
Andre R. Brunoni
JMJOSE GERALDO MILL
JOSE GERALDO MILL